TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH HEMATOPOIETIC GROWTH-FACTORS

被引:33
作者
GANSER, A
HOELZER, D
机构
关键词
D O I
10.1016/S0889-8588(18)30333-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:633 / 653
页数:21
相关论文
共 125 条
[61]  
JANOWSKAWIECZOREK A, 1991, BLOOD, V77, P1796
[62]  
JANSSEN JWG, 1989, BLOOD, V73, P248
[63]  
KARP JE, 1990, LEUKEMIA, V4, P553
[64]   NATURAL-KILLER CELL-MEDIATED INHIBITION OF BONE-MARROW COLONY FORMATION (CFU-GM) IN REFRACTORY-ANEMIA (PRELEUKEMIA) - EVIDENCE FOR PATIENT-SPECIFIC CELL-POPULATIONS [J].
KERNDRUP, G ;
HOKLAND, P .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (04) :457-462
[65]   TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR - A PRELIMINARY-REPORT [J].
KOBAYASHI, Y ;
OKABE, T ;
OZAWA, K ;
CHIBA, S ;
HINO, M ;
MIYAZONO, K ;
URABE, A ;
TAKAKU, F .
AMERICAN JOURNAL OF MEDICINE, 1989, 86 (02) :178-182
[66]   DIFFERENTIAL DOSE-RELATED HEMATOLOGICAL EFFECTS OF GM-CSF IN PANCYTOPENIA - EVIDENCE SUPPORTING THE ADVANTAGE OF LOW-DOSE OVER HIGH-DOSE ADMINISTRATION IN SELECTED PATIENTS [J].
KURZROCK, R ;
TALPAZ, M ;
GOMEZ, JA ;
ESTEY, EH ;
OBRIEN, S ;
HIRSCHGINSBERG, C ;
KOLLER, C ;
FREIREICH, EJ ;
GUTTERMAN, JU .
BRITISH JOURNAL OF HAEMATOLOGY, 1991, 78 (03) :352-358
[67]   PHASE-I STUDY OF RECOMBINANT HUMAN INTERLEUKIN-3 IN PATIENTS WITH BONE-MARROW FAILURE [J].
KURZROCK, R ;
TALPAZ, M ;
ESTROV, Z ;
ROSENBLUM, MG ;
GUTTERMAN, JU .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (07) :1241-1250
[68]  
Lindemann A, 1991, Eur Cytokine Netw, V2, P173
[69]   THE MYELODYSPLASTIC SYNDROMES - BIOLOGY AND IMPLICATIONS FOR MANAGEMENT [J].
LIST, AF ;
GAREWAL, HS ;
SANDBERG, AA .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) :1424-1441
[70]   GENERATION OF CYTOTOXIC NK CELLS IN PERIPHERAL-BLOOD AND BONE-MARROW OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA AFTER CONTINUOUS INFUSION WITH RECOMBINANT INTERLEUKIN-2 [J].
LOTZOVA, E ;
SAVARY, CA ;
SCHACHNER, JR ;
HUH, JO ;
MCCREDIE, K .
AMERICAN JOURNAL OF HEMATOLOGY, 1991, 37 (02) :88-99